The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Solomon, Scott D, Prof Dr, Zile, Michael, Prof, Pieske, Burkert, Prof, Voors, Adriaan, Prof, Shah, Amil, MD, Kraigher-Krainer, Elisabeth, MD, Shi, Victor, MD, Bransford, Toni, MD, Takeuchi, Madoka, MS, Gong, Jianjian, PhD, Lefkowitz, Martin, MD, Packer, Milton, Prof, McMurray, John JV, Prof
Published in The Lancet (British edition) (20.10.2012)
Published in The Lancet (British edition) (20.10.2012)
Get full text
Journal Article
The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction: A Phase II Randomised-Controlled Trial
Solomon, Scott D., MD, Zile, Michael, MD, Pieske, Burkert, MD, Voors, Adriaan A., MD, Shah, Amil, MD, Kraigher-Krainer, Elisabeth, MD, Shi, Victor, MD, Bransford, Toni, MD, Takeuchi, Madoka, MS, Gong, Jianjian, PhD, Lefkowitz, Martin, MD, Packer, Milton, MD, McMurray, John J.V., MD
Published in Journal of cardiac failure (01.11.2012)
Published in Journal of cardiac failure (01.11.2012)
Get full text
Journal Article